Abstracts

cccDNA SILENCING AND LIMITED DECAY OF INFECTED CELLS IN HIV-HBV (HBeAG-) DURING NUCs

Background: Hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (CHB) is characterized by lower serum HBV DNA levels than HBeAg-positive CHB. Nucleos(t)ide analogues (NUC), the mainstay of treatment for CHB, effectively suppress HBV replication and are associated with decreased covalently closed circular DNA (cccDNA) transcription in HBeAg-positive disease. However, the effects of NUCs on the…

SimpliciTB RESULTS AND HEPATIC SAFETY OF PRETOMANID REGIMENS +/- PYRAZINAMIDE

Background: Pre-clinical and early-phase studies of a bedaquiline-pretomanid-moxifloxacin-pyrazinamide (B-Pa-M-Z) regimen show significant treatment-shortening potential for TB. Pa has been studied clinically in various combinations, with and without Z. Safety has been carefully monitored in these studies. Methods: SimpliciTB study was an open-label safety and efficacy study in 303 DS-TB patients randomized 1:1 to 4-months BPaMZ…

HUMAN ANTI-ACE2 MONOCLONAL ANTIBODIES AS PAN-SARBECOVIRUS PROPHYLACTIC AGENTS

Background: Human monoclonal antibodies from convalescent individuals that target the SARS-CoV-2 spike protein have been deployed as therapeutics against SARS-CoV-2. However, nearly all of these antibodies have been rendered obsolete by SARS-CoV-2 variants that evolved to resist similar, naturally occurring antibodies. Moreover, Most SARS-CoV-2 specific antibodies are inactive against divergent sarbecoviruses Methods: By immunizing mice…

INHIBITION OF NEUTRAL SPHINGOMYELINASE 2 BLOCKS HIV-1 MATURATION

Background: Sphingomyelinases (SMases) are key enzymes that hydrolyze sphingomyelin (SM) to generate phosphorylcholine and ceramide. Ceramides at the plasma membrane (PM) are critical for a variety of biological functions, including the formation and stabilization of lipid rafts that are assembly sites for HIV. Neutral sphingomyelinase 2 (nSMase2) is the major sphingomyelinase in mammalian cells that…